American Journal of Neuroradiology 20:821-827 (5 1999)
© 1999 American Society of Neuroradiology
ARTICLE
Long-Term Changes of Magnetization Transfer–Derived Measures from Patients with Relapsing-Remitting and Secondary Progressive Multiple Sclerosis
a From the Neuroimaging Research Unit (M.A.R., G.M., M.F.) and the Clinical Trials Unit (M.R., G.C.), Department of Neuroscience, Scientific Institute Ospedale San Raffaele, University of Milan, Milan.
BACKGROUND AND PURPOSE: For cases of multiple sclerosis (MS), magnetization transfer (MT) imaging may provide more pathologically specific and accurate estimates of the disease process than does conventional imaging. In this study, we evaluated changes of the MT ratio (MTR) of newly enhancing lesions, the MTR of normal-appearing white matter (NAWM), the average lesion MTR, and the MT histogram-derived metrics during a 3-year follow-up period for patients with relapsing-remitting or secondary progressive MS.
METHODS: Dual-echo, conventional spin-echo, and MT images were obtained from seven patients with relapsing-remitting MS, seven patients with secondary progressive MS, and five age- and sex-matched control subjects at the time of study entry and 1, 13, and 37 months later.
RESULTS: Newly enhancing lesions in the patients with secondary progressive MS presented a more severe and significant MTR reduction during the follow-up period as compared with those in the relapsing-remitting group. In cases of secondary progressive MS, we also observed a significant reduction of the MTR values of the NAWM and a trend toward reduction of average lesion MTR values. The patients with MS had mean percentage changes of MT histogram-derived measures that were approximately two to 10 times higher than those of the control subjects.
CONCLUSION: This preliminary 3-year follow-up study shows that newly enhancing lesions and NAWM in patients with secondary progressive MS have significantly lower MTR values than do those in patients with relapsing-remitting MS. It also shows that the tissue damage that remains after enhancement ceases is more severe in secondary progressive disease.
This article has been cited by other articles:
 |
|
 |
|
  F. Agosta, M. Rovaris, E. Pagani, M. P. Sormani, G. Comi, and M. Filippi Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis Brain, October 1, 2006; 129(10): 2620 - 2627. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Filippi, M. A. Rocca, E. Pagani, G. Iannucci, M. P. Sormani, F. Fazekas, S. Ropele, O. R. Hommes, and G. Comi European Study on Intravenous Immunoglobulin in Multiple Sclerosis: Results of Magnetization Transfer Magnetic Resonance Imaging Analysis Arch Neurol, September 1, 2004; 61(9): 1409 - 1412. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Q. Zhou, Y. M. Zhu, J. Grimaud, M. Hermier, M. Rovaris, and M. Filippi A New Method for Analyzing Histograms of Brain Magnetization Transfer Ratios: Comparison with Existing Techniques AJNR Am. J. Neuroradiol., August 1, 2004; 25(7): 1234 - 1241. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. M. Boneschi, M. Rovaris, G. Comi, and M. Filippi The use of magnetic resonance imaging in multiple sclerosis: lessons learned from clinical trials Multiple Sclerosis, August 1, 2004; 10(4): 341 - 347. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Inglese, J.H.T.M. van Waesberghe, M. Rovaris, K. Beckmann, F. Barkhof, D. Hahn, L. Kappos, D.H. Miller, C. Polman, C. Pozzilli, et al. The effect of interferon {beta}-1b on quantities derived from MT MRI in secondary progressive MS Neurology, March 11, 2003; 60(5): 853 - 860. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Rovaris, M. Bozzali, G. Iannucci, A. Ghezzi, D. Caputo, E. Montanari, A. Bertolotto, R. Bergamaschi, R. Capra, G. L. Mancardi, et al. Assessment of Normal-Appearing White and Gray Matter in Patients With Primary Progressive Multiple Sclerosis: A Diffusion-Tensor Magnetic Resonance Imaging Study Arch Neurol, September 1, 2002; 59(9): 1406 - 1412. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. McFarland, F. Barkhof, J. Antel, and D. Miller The role of MRI as a surrogate outcome measure in multiple sclerosis Multiple Sclerosis, September 1, 2002; 8(1_suppl): 40 - 51. [Abstract] [PDF]
|
|
|
|
|
|
J. Wolinsky MRI aspects of secondary progressive multiple sclerosis Multiple Sclerosis, September 1, 2002; 8(1_suppl): 85 - 87. [PDF]
|
|
|
|
 |
|
 M. J. Lowe, M. D. Phillips, J. T. Lurito, D. Mattson, M. Dzemidzic, and V. P. Mathews Multiple Sclerosis: Low-Frequency Temporal Blood Oxygen Level-Dependent Fluctuations Indicate Reduced Functional Connectivity—Initial Results Radiology, July 1, 2002; 224(1): 184 - 192. [Abstract] [Full Text]
|
|
|
|
|
|
M. Filippi and R. I. Grossman MRI techniques to monitor MS evolution: The present and the future Neurology, April 23, 2002; 58(8): 1147 - 1153. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H F McFarland, F Barkhof, J Antel, and D H Miller The role of MRI as a surrogate outcome measure in multiple sclerosis Multiple Sclerosis, February 1, 2002; 8(1): 40 - 51. [Abstract] [PDF]
|
|
|
|
|
|
J S Wolinsky MRI aspects of secondary progressive multiple sclerosis Multiple Sclerosis, February 1, 2002; 8(1): 85 - 87. [PDF]
|
|
|
|
|
|
F. Barkhof, J.-H. T. M. van Waesberghe, M. Filippi, T. Yousry, D. H. Miller, D. Hahn, A. J. Thompson, L. Kappos, P. Brex, C. Pozzilli, et al. T1 hypointense lesions in secondary progressive multiple sclerosis: effect of interferon beta-1b treatment Brain, July 1, 2001; 124(7): 1396 - 1402. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Filippi, M. Rovaris, G. Iannucci, S. Mennea, M. P. Sormani, and G. Comi Whole brain volume changes in patients with progressive MS treated with cladribine Neurology, December 12, 2000; 55(11): 1714 - 1718. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Rovaris, M. Bozzali, G. Santuccio, G. Iannucci, M. P. Sormani, B. Colombo, G. Comi, and M. Filippi Relative contributions of brain and cervical cord pathology to multiple sclerosis disability: a study with magnetisation transfer ratio histogram analysis J. Neurol. Neurosurg. Psychiatry, December 1, 2000; 69(6): 723 - 727. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Filippi Enhanced magnetic resonance imaging in multiple sclerosis Multiple Sclerosis, October 1, 2000; 6(5): 320 - 326. [Abstract] [PDF]
|
|
|
|
|
|
M. Filippi, C. Tortorella, and M. Bozzali Normal-appearing white matter changes in multiple sclerosis: the contribution of magnetic resonance techniques Multiple Sclerosis, August 1, 1999; 5(4): 273 - 282. [Abstract] [PDF]
|
|